PuSH - Publikationsserver des Helmholtz Zentrums München

He, M.* ; Ding, M.* ; Chocholoušková, M.* ; Chin, C.F.* ; Engvall, M.* ; Malmgren, H.* ; Wagner, M. ; Lauffer, M.C.* ; Heisinger, J.* ; Malicdan, M.C.V.* ; Allamand, V.* ; Durbeej, M.* ; Delgado-Vega, A.M.* ; Sejersen, T.* ; Nordgren, A.* ; Torta, F.* ; Silver, D.L.*

SPNS1 variants cause multi-organ disease and implicate lysophospholipid transport as critical for mTOR-regulated lipid homeostasis.

J. Clin. Invest. 135:e193099 (2025)
Postprint DOI PMC
Open Access Gold
SPNS1 is a lysosomal transporter mediating the salvage of lysoglycerophospholipids, the degradative products of lysosomal phospholipid catabolism. However, a role of lysolipid transport and salvage in regulating cellular lipid homeostasis and in disease is lacking. Here, we identified two families with biallelic SPNS1 loss-of-function variants that presented primarily with progressive liver and striated muscle injury. Patient fibroblasts accumulated lysophospholipids including lysoplasmalogens and cholesterol in lysosomes with reduced cellular plasmalogens. Notably, SPNS1 deficiency resulted in reduced biogenesis of cytosolic lipid droplets containing triglycerides and cholesteryl esters. Mechanistically, we found that lysophospholipids transported by SPNS1 into the cytosol quantitatively contributed to triglyceride synthesis while lysosomal buildup of lyso-ether-phospholipid inhibited lysosomal cholesterol egress, effects that were enhanced with inhibition of mTOR. These findings support a gene-disease association and reveal connectivity between lysosomal transport of lysophospholipids and storage of reserve cellular energy as triglyceride and in the regulation of cholesterol homeostasis, processes that become important under nutrient limitation.
Impact Factor
Scopus SNIP
Altmetric
0.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Cell Biology ; Cholesterol ; Lipidomics ; Lysosomes ; Metabolism
Sprache englisch
Veröffentlichungsjahr 2025
HGF-Berichtsjahr 2025
ISSN (print) / ISBN 0021-9738
e-ISSN 1558-8238
Quellenangaben Band: 135, Heft: 17, Seiten: , Artikelnummer: e193099 Supplement: ,
Verlag American Society of Clinical Investigation
Begutachtungsstatus Peer reviewed
POF Topic(s) 30205 - Bioengineering and Digital Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-503200-001
Scopus ID 105015172735
PubMed ID 40608416
Erfassungsdatum 2025-07-16